CDC: US supply of yellow fever vaccine to completely run out by mid-2017Supplies of the only U.S.-licensed yellow fever vaccine will be depleted by mid-2017 due to a manufacturing issue, reports the CDC in its most recent Morbidity and Mortality Weekly Report. Sanofi Pasteur, the vaccines unit of Sanofi, manufactures the U.S. yellow fever vaccine. Due to the complexity of importing and monitoring use of the French vaccine under the FDA's expanded access provision, the amount of U.S. clinics offering a yellow fever vaccine will drop from about 4,000 to 250, according to the CDC. Sanofi is working with the CDC and the Food and addiction Administration to import a similar yellow fever vaccine from the drugmaker's French division in the wake of the shortage. More articles on supply chain:CIPS launches supply chain risk-assessment toolSurvey: 72% of supply chain leaders expect blockchain to simplify logistics4 latest FDA approvals© Copyright ASC COMMUNICATIONS 2017.
CDC warns of yellow fever vaccine shortage in US
Because of the shortage, the CDC says it collaborated with Sanofi Pasteur to get a limited amount of a second yellow fever vaccine, Stamaril. GRAND RAPIDS, Mich. (WOOD) — The Centers for Disease Control and Prevention is piecing together a plan as the U.S. supply of yellow fever vaccine runs out. —-Online:CDC on Yellow Fever vaccine shortageShare this: EmailPrintFacebookTwitterGooglePinterestMoreLinkedInTumblrReddit However, the Stamaril vaccine will only be available at approximately 250 of the 4,000 clinics that normally provide yellow fever vaccines. The CDC said a manufacturing issue last year at Sanofi Pasteur in France affected production of YF-VAX, which is the only yellow fever vaccine licensed for use in the United States.collected by :Lucy William
No comments:
Post a Comment